In silico toxicology protocols.

The present publication surveys several applications of in silico (i.e., computational) toxicology approaches across different industries and institutions. It highlights the need to develop standardized protocols when conducting toxicity-related predictions. This contribution articulates the information needed for protocols to support in silico predictions for major toxicological endpoints of concern (e.g., genetic toxicity, carcinogenicity, acute toxicity, reproductive toxicity, developmental toxicity) across several industries and regulatory bodies. Such novel in silico toxicology (IST) protocols, when fully developed and implemented, will ensure in silico toxicological assessments are performed and evaluated in a consistent, reproducible, and well-documented manner across industries and regulatory bodies to support wider uptake and acceptance of the approaches. The development of IST protocols is an initiative developed through a collaboration among an international consortium to reflect the state-of-the-art in in silico toxicology for hazard identification and characterization. A general outline for describing the development of such protocols is included and it is based on in silico predictions and/or available experimental data for a defined series of relevant toxicological effects or mechanisms. The publication presents a novel approach for determining the reliability of in silico predictions alongside experimental data. In addition, we discuss how to determine the level of confidence in the assessment based on the relevance and reliability of the information.

Tudor I. Oprea | Naomi L Kruhlak | Lidiya Stavitskaya | David Allen | Jean-Pierre Valentin | Romualdo Benigni | Barry Hardy | Patricia Ruiz | Véronique Gervais | Adam Woolley | David Woolley | Elena Lo Piparo | Rositsa Serafimova | Alexander Amberg | Steve Gutsell | Natalie Burden | Scott Miller | Marlene T Kim | Kevin P Cross | Masamitsu Honma | Nichola Gellatly | Grace Patlewicz | Tudor I Oprea | Marlene T. Kim | Andrea-Nicole Richarz | Susanne Glowienke | Andrew Teasdale | Glenn J Myatt | Ernst Ahlberg | Yumi Akahori | Lennart T Anger | Aynur Aptula | Scott Auerbach | Lisa Beilke | Phillip Bellion | Joel Bercu | Ewan D Booth | Dave Bower | Alessandro Brigo | Zoryana Cammerer | Mark T D Cronin | Laura Custer | Magdalena Dettwiler | Krista Dobo | Kevin A Ford | Marie C Fortin | Samantha E Gad-McDonald | Kyle P Glover | Jacky Van Gompel | James S Harvey | Jedd Hillegass | Jui-Hua Hsieh | Chia-Wen Hsu | Kathy Hughes | Candice Johnson | Robert Jolly | David Jones | Ray Kemper | Michelle O Kenyon | Sunil A Kulkarni | Klaus Kümmerer | Penny Leavitt | Bernhard Majer | Scott Masten | Janet Moser | Moiz Mumtaz | Wolfgang Muster | Louise Neilson | Alexandre Paulino | Mark Powley | Donald P Quigley | M Vijayaraj Reddy | Benoit Schilter | Wendy Simpson | Reinhard Stidl | Diana Suarez-Rodriguez | David T Szabo | Alejandra Trejo-Martin | Anna Vuorinen | Brian A Wall | Pete Watts | Angela T White | Joerg Wichard | Kristine L Witt | Craig Zwickl | Catrin Hasselgren | Donald P. Quigley | Krista L Dobo | T. Oprea | G. Myatt | S. Auerbach | G. Patlewicz | K. Cross | R. Benigni | W. Muster | A. Brigo | N. Kruhlak | M. Cronin | J. Hsieh | K. Witt | J. Wichard | M. Honma | S. Gutsell | S. Masten | M. Mumtaz | Chia-Wen Hsu | J. Valentin | R. Serafimova | W. Simpson | K. Kümmerer | B. Schilter | A. Aptula | David R. Jones | Ernst Ahlberg | V. Gervais | A. Vuorinen | N. Gellatly | N. Burden | S. Kulkarni | A. Amberg | R. Jolly | Kevin A. Ford | Elena Lo Piparo | A. Teasdale | J. Harvey | D. Bower | J. Bercu | A. Richarz | M. Kenyon | L. Stavitskaya | M. Powley | L. Anger | D. Allen | M. Fortin | M. V. Reddy | C. Johnson | Lisa Beilke | S. Glowienke | C. Hasselgren | J. Hillegass | Scott Miller | L. Neilson | Alexandre Paulino | R. Stidl | D. Szabo | B. Wall | Angela White | D. Woolley | C. Zwickl | E. Booth | P. Ruiz | K. Hughes | A. Woolley | Y. Akahori | J. van Gompel | K. Dobo | L. Custer | P. Bellion | D. Suarez-Rodriguez | Ray Kemper | B. Hardy | Alejandra Trejo-Martin | Samantha Gad-McDonald | P. Watts | Zoryana Cammerer | Penny Leavitt | Janet Moser | Kyle P. Glover | M. Dettwiler | B. Majer | James Harvey | M. Reddy

[1]  M M Mumtaz,et al.  A Weight-of-Evidence Approach for Assessing Interactions in Chemical Mixtures , 1992, Toxicology and industrial health.

[2]  T W Schultz,et al.  A strategy for structuring and reporting a read-across prediction of toxicity. , 2015, Regulatory toxicology and pharmacology : RTP.

[3]  G Patlewicz,et al.  Building scientific confidence in the development and evaluation of read-across. , 2015, Regulatory toxicology and pharmacology : RTP.

[4]  R D Benz,et al.  (Q)SAR Modeling and Safety Assessment in Regulatory Review , 2012, Clinical pharmacology and therapeutics.

[5]  B. Schwetz,et al.  Use of mechanistic and pharmacokinetic data for risk assessment at the National Institute of Environmental Health Sciences (NIEHS). , 1995, Toxicology letters.

[6]  Bruno Hubesch,et al.  Workshop: use of "read-across" for chemical safety assessment under REACH. , 2013, Regulatory toxicology and pharmacology : RTP.

[7]  Nigel Greene,et al.  In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey. , 2012, Regulatory toxicology and pharmacology : RTP.

[8]  Lisa Beilke,et al.  In Silico Tools and their Application , 2017 .

[9]  Andrew P. Worth,et al.  The Integrated Use of Models for the Properties and Effects of Chemicals by means of a Structured Workflow , 2008 .

[10]  Vinicius M. Alves,et al.  Alarms about structural alerts. , 2016, Green chemistry : an international journal and green chemistry resource : GC.

[11]  Nicholas Ball,et al.  Use of category approaches, read-across and (Q)SAR: general considerations. , 2013, Regulatory toxicology and pharmacology : RTP.

[12]  Andrew Teasdale,et al.  ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .

[13]  Alexander Amberg,et al.  Do Carboxylic/Sulfonic Acid Halides Really Present a Mutagenic and Carcinogenic Risk as Impurities in Final Drug Products? , 2015 .

[14]  A M Richard,et al.  An automated curation procedure for addressing chemical errors and inconsistencies in public datasets used in QSAR modelling$ , 2016, SAR and QSAR in environmental research.

[15]  Glenn J. Myatt,et al.  CHAPTER 9:In silico Toxicology: An Overview of Toxicity Databases, Prediction Methodologies, and Expert Review , 2017 .

[16]  Emilio Benfenati,et al.  (Q)SAR tools for priority setting: A case study with printed paper and board food contact material substances. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  L. Theodore,et al.  Toxic Substances Control Act (TSCA) , 2006 .

[18]  John R. Bucher,et al.  Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.

[19]  Jeanne Goshorn,et al.  Selected Resources for Emergency and Disaster Preparedness and Response from the United States National Library of Medicine , 2008 .

[20]  Ferran Sanz,et al.  Applicability Domain Analysis (ADAN): A Robust Method for Assessing the Reliability of Drug Property Predictions , 2014, J. Chem. Inf. Model..

[21]  Tian Zhang,et al.  Development of quantitative structure activity relationship (QSAR) model for disinfection byproduct (DBP) research: A review of methods and resources. , 2015, Journal of hazardous materials.

[22]  Andrew P Worth,et al.  Validation of Computational Methods. , 2016, Advances in experimental medicine and biology.

[23]  Marlene Ågerstrand,et al.  Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies , 2015 .

[24]  Karen Blackburn,et al.  A framework to facilitate consistent characterization of read across uncertainty. , 2014, Regulatory toxicology and pharmacology : RTP.

[25]  Moiz Mumtaz,et al.  Introduction to Mixtures Toxicology and Risk Assessment , 2010 .

[26]  Vladimir B Bajic,et al.  In silico toxicology: computational methods for the prediction of chemical toxicity , 2016, Wiley interdisciplinary reviews. Computational molecular science.

[27]  Kevin A Ford,et al.  Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods. , 2016, ILAR journal.

[28]  Steven J Enoch,et al.  Adverse Outcome Pathway (AOP) Informed Modeling of Aquatic Toxicology: QSARs, Read-Across, and Interspecies Verification of Modes of Action. , 2016, Environmental science & technology.

[29]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[30]  Lidiya Stavitskaya,et al.  Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses. , 2016, Regulatory toxicology and pharmacology : RTP.

[31]  T M Martin,et al.  Comparison of global and mode of action-based models for aquatic toxicity , 2015, SAR and QSAR in environmental research.

[32]  N. Heinrich,et al.  Computational Chemistry in the Pharmaceutical Industry: From Childhood to Adolescence , 2015, ChemMedChem.

[33]  Andrew Teasdale,et al.  Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development , 2017, Regulatory toxicology and pharmacology : RTP.

[34]  Karen Blackburn,et al.  A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR-based toxicological assessments. , 2010, Regulatory toxicology and pharmacology : RTP.

[35]  Kathleen Stanton,et al.  Quantifying the benefits of using read-across and in silico techniques to fulfill hazard data requirements for chemical categories. , 2016, Regulatory toxicology and pharmacology : RTP.

[36]  Richard A Becker,et al.  Read-across approaches--misconceptions, promises and challenges ahead. , 2014, ALTEX.

[37]  Thomas Hartung,et al.  "ToxRTool", a new tool to assess the reliability of toxicological data. , 2009, Toxicology letters.

[38]  U. Tillmann,et al.  A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.

[39]  Klaus Kümmerer,et al.  Designing green derivatives of β-blocker Metoprolol: a tiered approach for green and sustainable pharmacy and chemistry. , 2014, Chemosphere.

[40]  Stephen W. Edwards,et al.  Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  Andrew Worth,et al.  Ab initio chemical safety assessment: A workflow based on exposure considerations and non-animal methods , 2017, Computational toxicology.

[42]  Scott Boyer,et al.  Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. , 2013, Regulatory toxicology and pharmacology : RTP.

[43]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[44]  Andrew Worth,et al.  Establishing the level of safety concern for chemicals in food without the need for toxicity testing. , 2014, Regulatory toxicology and pharmacology : RTP.

[45]  Mark W Powley,et al.  (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission. , 2015, Regulatory toxicology and pharmacology : RTP.

[46]  M Verwei,et al.  Development of a QSAR for worst case estimates of acute toxicity of chemically reactive compounds. , 2007, Toxicology letters.

[47]  Raymond M Agius,et al.  Progress with Structure–Activity Relationship modelling of occupational chemical respiratory sensitizers , 2017, Current opinion in allergy and clinical immunology.

[48]  Alexandre Santos Aguiar,et al.  Weight of evidence , 2008 .

[49]  Lidiya Stavitskaya,et al.  Establishing best practise in the application of expert review of mutagenicity under ICH M7. , 2015, Regulatory toxicology and pharmacology : RTP.

[50]  Hao Zhu,et al.  t4 report*: Toward Good Read-Across Practice (GRAP) Guidance , 2016, ALTEX.